Chemical Component Summary

NameTAZOBACTAM TRANS-ENAMINE INTERMEDIATE
Identifiers(2S,3S)-3-methyl-2-[[(E)-3-oxoprop-1-enyl]amino]-3-sulfino-4-(1,2,3-triazol-1-yl)butanoic acid
FormulaC10 H14 N4 O5 S
Molecular Weight302.307
TypeNON-POLYMER
Isomeric SMILESC[C@](Cn1ccnn1)([C@H](C(=O)O)N\C=C\C=O)S(=O)=O
InChIInChI=1S/C10H14N4O5S/c1-10(20(18)19,7-14-5-4-12-13-14)8(9(16)17)11-3-2-6-15/h2-6,8,11,20H,7H2,1H3,(H,16,17)/b3-2+/t8-,10-/m0/s1
InChIKeyANZZKUOZZHRUQC-QZWDGIGVSA-N

Chemical Details

Formal Charge0
Atom Count34
Chiral Atom Count2
Bond Count34
Aromatic Bond Count5

Drug Info: DrugBank

DrugBank IDDB03445 
NameTazobactam trans-enamine intermediate
Groups experimental
Synonyms
  • Tazobactam trans-enamine intermediate
  • Tazobactam Trans-Enamine Intermediate

Drug Targets

NameTarget SequencePharmacological ActionActions
Beta-lactamase SHV-1MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASG...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 5289443